Finally, the use of computerized decision support for insulin dosing in type 2 diabetes yielded a high level of agreement with standard clinical assessments (97%) and was perceived to precipitate a reduction in treatment decision-making errors [40]. This evidence concerns the gene INS and type 2 diabetes mellitus.